Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metal-based antitumour drugs in the post genomic era

1 Jan 2006

Abstract excerpt

The discovery of new metal-based antitumour drugs, whether cisplatin derivatives or those based on other metals, has been largely based on cell viability assays (IC50 values) and compounds that bind to DNA. This approach has been applied for more than 30 years during which time very few new drugs have entered clinical use. In this article we discuss what the future holds for metal-based drugs, in particular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferrocene Chemistry and Applications
Share to Metal complexes synthesis and properties
Share to Radiopharmaceutical Chemistry and Applications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16609762
DOI: 10.1039/b601840h

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metal-based antitumour drugs in the post genomic eraPMID 16609762Read ↗

Progress of Metal‐Based Anticancer Chemotherapeutic Agents in Last two Decades and their Comprehensive Biological (DNA/RNA Binding, Cleavage and Cytotoxicity Activity) StudiesSemantic proximity Read ↗

Metal-based anticancer drugs: From a past anchored in platinum chemistry to a post-genomic future of diverse chemistry and biologySemantic proximity Read ↗

Metallodrugs: an approach against invasion and metastasis in cancer treatmentSemantic proximity Read ↗

Metal Complexes as DNA Synthesis and/or Repair Inhibitors: Anticancer and Antimicrobial AgentsSemantic proximity Read ↗

Third row transition metals for the treatment of cancerSemantic proximity Read ↗

Platinum Complexes as Anticancer AgentsSemantic proximity Read ↗

Interactions of Metal Ions with DNA, Its Constituents and Derivatives, which may be Relevant for Anticancer ResearchSemantic proximity Read ↗

Copper: An Intracellular Achilles’ Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer TherapeuticsSemantic proximity Read ↗

Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer TherapySemantic proximity Read ↗

From coins to cancer therapy: Gold, silver and copper complexes targeting human topoisomerasesSemantic proximity Read ↗

Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeuticsSemantic proximity Read ↗

Zinc Oxide Nanoparticles and Cancer Chemotherapy: Helpful Tools for Enhancing Chemo-sensitivity and Reducing Side Effects?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.